MedTrace Logo

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

NCT00392236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2017-10-25

Study results available
· View outcomes & findings →

Summary

This study will determine whether using a pager improves medication adherence in people with schizophrenia.

Conditions

Interventions

DEVICE

2-way pager

Participants will receive messages daily to take their medication via a 2-way pager for 6 months. Once the message is received the participant will respond whether or not he/she took the medication and reason for not taking.

BEHAVIORAL

Treatment as usual

Participants will receive treatment as usual.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Northwell Health

    lead OTHER

Principal Investigators

  • Delbert G. Robinson, MD · Northwell Health

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00392236 on ClinicalTrials.gov